|
Re: NFK meeting
|
4
|
Resverlogix Corp.
|
Feb 19, 2020 06:58PM
|
|
Re: NFK meeting
|
3
|
Resverlogix Corp.
|
Feb 19, 2020 08:19PM
|
|
Re: Next trials after BETonMACE
|
2
|
Resverlogix Corp.
|
May 06, 2019 08:16AM
|
|
Re: Next private placement/licensing agreement
|
8
|
Resverlogix Corp.
|
Feb 06, 2019 12:29PM
|
|
Re: Next private placement/licensing agreement
|
3
|
Resverlogix Corp.
|
Feb 07, 2019 11:24AM
|
|
Re: Next News Release
|
2
|
Resverlogix Corp.
|
May 19, 2017 10:47AM
|
|
Re: Next News Release
|
|
Resverlogix Corp.
|
May 19, 2017 11:14AM
|
|
Re: Next Hurdle
|
3
|
Resverlogix Corp.
|
Jan 05, 2018 12:12PM
|
|
Re: Next Hurdle
|
3
|
Resverlogix Corp.
|
Jan 05, 2018 01:14PM
|
|
Re: Next Hurdle
|
1
|
Resverlogix Corp.
|
Jan 05, 2018 01:21PM
|
|
Re: News: Bioasis study shows MTfp-I2S crosses barrier to CNS
|
|
BIOASIS TECHNOLOGIES INC
|
Jul 31, 2015 09:04PM
|
|
Re: News,
|
5
|
Resverlogix Corp.
|
Jun 27, 2019 04:10PM
|
|
Re: News! - COVID 19 pre-clinical and clinical research trials
|
4
|
Resverlogix Corp.
|
Jun 01, 2020 09:39AM
|
|
Re: News Release: RESVERLOGIX ANNOUNCES PARTICIPATION IN UPCOMING CONFERENCES
|
3
|
Resverlogix Corp.
|
Sep 12, 2016 09:36AM
|
|
Re: News Release Issued: May 24, 2016 (4:54pm)
|
3
|
Resverlogix Corp.
|
May 24, 2016 08:35PM
|
|
Re: News out...an extension it is
|
1
|
Resverlogix Corp.
|
Aug 28, 2017 09:07AM
|
|
Re: News on Amgen's collesteral drug, Repatha; poor sales / resistant payer uptake
|
3
|
Resverlogix Corp.
|
Apr 27, 2017 12:50PM
|
|
Re: News on Amgen's collesteral drug, Repatha; poor sales / resistant payer uptake
|
5
|
Resverlogix Corp.
|
Apr 26, 2017 08:14PM
|
|
Re: News on 250 Events, Third Eye - Now what? Anything before Top-Line?
|
2
|
Resverlogix Corp.
|
May 06, 2019 09:29AM
|
|
Re: News from a Chinese/Japenese Article about Zenith
|
2
|
Zenith Epigenetics
|
Oct 26, 2016 12:01PM
|
